Market Research Logo

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2017

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2017

Summary

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2017, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q3 2017. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in Q3 2017 with 1,077 deals worth USD90.3 billion, as compared 1,113 worth USD114.1 billion in Q3 2016. On a quarter-on-quarter basis, the number of deals and deal values decreased in Q3 2017, when compared to 1,153 deals worth USD92.3 billion in Q2 2017. The pharmaceutical and healthcare industry reported a decrease in upfront payments in licensing agreements with USD347.3m in Q3 2017, as compared USD753.8m in Q3 2016. On a quarter-on-quarter basis, the upfront payments reported a decrease in Q3 2017, when compared to USD735.8m in Q2 2017. Deals in oncology therapeutics market registered a decrease with 362 deals in Q3 2017, compared to 392 deals in Q2 2017. North America reported a decrease in the number of deals from 726 in Q2 2017 to 676 in Q3 2017.

Scope

  • Analysis of the market trends for the pharmaceutical industry in the global arena.
  • Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
  • Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
  • Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
  • Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
  • Analysis of partnership and licensing deals based on clinical stage of development of products.
  • Summary of the pharmaceutical deals globally in the five quarters.
  • Information on the top deals happened in the pharmaceutical industry.
  • Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
  • League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
  • Enhance your decision making capability in a more rapid and time sensitive manner.
  • Find out the major deal performing segments for investments in your industry.
  • Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
  • Identify companies that are aggressively looking to raise capital in the market
  • Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
  • Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
  • Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
  • Identify growth segments and opportunities in each region within the industry.
  • Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.


  • Executive Summary
    • Independent Pharmaceutical & Healthcare Research
      • M&A Trends and Analysis
        • Table Figure 1: Executive Summary - Number Of Deals Q3 2016-Q3 2017
        • Table Figure 2: Executive Summary - Licensing Deals By Payment Mode Q3 2016-Q3 2017
        • Table Figure 3: Executive Summary - Number Of Deals By Therapy Q3 2017
    • Deals In Pharmaceutical & Healthcare Industry Decreased In Q3 2017
      • Pharmaceutical & Healthcare, Deal Summary
        • Table Figure 4: Executive Summary - Q3 2017 Number Of Deals By Region
  • Pharmaceuticals & Healthcare, Global, Deal Summary, Q3 2017
    • Pharmaceuticals & Healthcare, Global, Deals Analysis, Q3 2017
      • Table Figure 5: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q3 2017
      • Table Figure 6: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), Q3 2017
    • Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q3 2017
      • Table Figure 7: Pharmaceuticals & Healthcare, Global, Deal Values (%), Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), Q3 2017
    • Pharmaceuticals & Healthcare, Global, Top Deals, Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Top Deals, Q3 2017
      • Gilead Sciences Acquires Kite Pharma for USD11.9 Billion
      • AstraZeneca Enters into Agreement with Merck
      • Baotou Dongbao Bio Tech to Raise up to USD5.6 Billion in Private Placement of Shares
      • Sanofi Enters into Licensing Agreement with Ablynx
      • Gilead Sciences Raises USD3 Billion in Public Offering of Notes
  • Pharmaceuticals & Healthcare, Global, Deals Summary, by Type
    • Pharmaceuticals & Healthcare, Global, M&A, Q3 2017
      • Table Figure 8: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Top M&A Deals in Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top M&A Deals, Q3 2017
      • Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q3 2016 - Q3 2017
        • Table Figure 9: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q3 2016 - Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, , Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q3 2017
      • Table Figure 10: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), Q3 2016 - Q3 2017
      • Top Initial Public Offerings in Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Initial Public Offering Deals, Q3 2017
      • Top Secondary Offerings in Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Secondary Offering Deals, Q3 2017
      • Top PIPE Deals in Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top PIPE Deals, Q3 2017
      • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q3 2016 - Q3 2017
        • Table Figure 11: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), , Q3 2016 - Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q3 2017
      • Table Figure 12: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Top Venture Financing Deals in Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Venture Capital Deals, Q3 2017
      • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q3 2017
        • Table Figure 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q3 2017
      • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q3 201
        • Table Figure 14: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), Q3 2017
      • Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q3 2016 - Q3 2017
        • Table Figure 15: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q3 2016 - Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q3 2016 - Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q3 2016 - Q3 2017
        • Table Figure 16: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q3 2016 - Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q3 2017
      • Table Figure 17: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Top Private Equity Deals in Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q3 2017
      • Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q3 2016 - Q3 2017
        • Table Figure 18: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q3 2016 - Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals
  • Pharmaceuticals & Healthcare, Global, Partnership Deals, Q3 2017
    • Table Figure 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Table Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q3 2016 - Q3 2017
      • Table Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2017
      • Table Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q3 2017
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q3 2016 - Q3 2017
      • Table Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Figure 24: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q3 2016 - Q3 2017
  • Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q3 2017
    • Pharmaceutical & Healthcare, Global, Licensing Agreements, Q3 2017
      • Table Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Deal Values, Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Upfront Payment, Q3 2017
      • Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q3 2017
        • Table Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Milestone Payment, Q3 2017
    • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q3 2016 - Q3 2017
      • Table Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q3 2016 - Q3 2017
      • Table Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Figure 31: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q3 2016 - Q3 2017
      • Table Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment and Deal Values (US$ m), Q3 2016 - Q3 2017
  • Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
    • Pharmaceuticals & Healthcare, Global, Oncology Deals, Q3 2017
      • Table Figure 33: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Oncology - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q3 2017
      • Table Figure 34: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Central Nervous System - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q3 2017
      • Table Figure 35: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Infectious Disease - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Immunology Deals, Q3 2017
      • Table Figure 36: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Immunology - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q3 2017
      • Table Figure 37: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Metabolic Disorders - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q3 2017
      • Table Figure 38: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Cardiovascular - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q3 2017
      • Table Figure 39: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Gastrointestinal - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Musculoskeletal Disorders Deals, Q3 2017
      • Table Figure 40: Pharmaceuticals & Healthcare, Global, Musculoskeletal Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Musculoskeletal Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Musculoskeletal Disorders - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q3 2017
      • Table Figure 41: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Respiratory - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q3 2017
      • Table Figure 42: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Dermatology - Deals of the Quarter
  • Deal Summary by Geography
    • Pharmaceuticals & Healthcare, North America Region, Deals, Q3 2017
      • Table Figure 43: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • North America - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Europe Region, Deals, Q3 2017
      • Table Figure 44: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Europe - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q3 2017
      • Table Figure 45: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Asia-Pacific - Deals of the Quarter
    • Pharmaceuticals & Healthcare, Rest of the World, Deals, Q3 2017
      • Table Figure 46: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Rest of the World - Deals of the Quarter
  • Pharmaceuticals & Healthcare, Global, Top Advisors
    • Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q3 2016 - Q3 2017
      • Table Figure 47: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
    • Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q3 2016 - Q3 2017
      • Table Figure 48: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
      • Table Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q3 2016 - Q3 2017
  • Further Information
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclosure information
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report